SCHEMBL4474043

SCHEMBL4474043

CCC(C)C1CN(C(=O)c2cc(CC(C)C)c(C(=O)O)nn2)CCN1C

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 4/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
CHRM1 P11229 1/20 0.32
HCAR2 Q8TDS4 1/20 0.31
TSHR P16473 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSP90AA1 P07900 2/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
PKM P14618 1/20 0.30
MAPK1 P28482 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4474032 1.00 KDM5A (0.33) KDM5ALMNAMAPTHTTCHRM1
SCHEMBL4484410 0.90 KDM5A (0.34) KDM5ALMNAMAPTHTTTSHR
SCHEMBL4484417 0.90 KDM5A (0.34) KDM5ALMNAMAPTHTTTSHR
SCHEMBL4485035 0.89 KDM5A (0.33) KDM5AHSP90AA1NPC1RAB9A
SCHEMBL4485028 0.89 KDM5A (0.33) KDM5AHSP90AA1NPC1RAB9A
SCHEMBL13600530 0.86 KDM5A (0.30) KDM5A
SCHEMBL13600526 0.85 CNR2 (0.33) KDM5A
SCHEMBL13607432 0.85 KDM5A (0.32) KDM5ALMNAMAPTHTTTSHR
SCHEMBL3128705 0.79 GNE (0.40) LMNAMAPTHTTTSHRSMN1; SMN2
SCHEMBL4489342 0.78 NPC1 (0.31) NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298835-A1 NOVEL SCAFFOLDS FOR ALPHA-HELIX MIMICRY THE SCRIPPS RESEARCH INSTITUTE (US) 2009-12-03 US disclosed
US-7579350-B2 5-Isobutyl-6-4-isopropyl-4,5-dihydro-oxazol-2-yl)-pyridazin-3-yl]-piperidin-1-yl-methanone; mimetics of functionalized pyridazine derivatives having low molecular weight; alpha-helical binding ligands of natural receptors such as those of the peptide galanin or the protein Bcl THE SCRIPPS RESEARCH INSTITUTE (US) 2009-08-25 US disclosed
US-20060205728-A1 Novel scaffolds for beta-helix mimicry THE SCRIPPS RESEARCH INSTITUTE (US) 2006-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205728-A1 Novel scaffolds for beta-helix mimicry HRH1, HEATR1, HSPH1 KDM5A 4283/4885LMNA 2255/4885MAPT 1861/4885
US-20090298835-A1 NOVEL SCAFFOLDS FOR ALPHA-HELIX MIMICRY HRH1, HEATR1, PLEKHA1 KDM5A 4087/4885LMNA 2229/4885MAPT 1806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.